Search Results - "Stone RM"

Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.

Authors: Stock W Johnson JL Stone RM et al.

Source: Cancer (0008543X). Jan2013, Vol. 119 Issue 1, p90-98. 9p.

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

Authors: Banerji V Frumm SM Ross KN et al.

Source: Journal of Clinical Investigation. Mar2012, Vol. 122 Issue 3, p935-947. 13p.

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Authors: Koreth J Schlenk R Kopecky KJ et al.

Source: JAMA: Journal of the American Medical Association. 6/10/2009, Vol. 301 Issue 22, p2349-2361. 13p.

Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).

Authors: Grinblatt DL Yu D Hars V et al.

Source: Cancer (0008543X). 1/1/2009, Vol. 115 Issue 1, p84-93. 10p.

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Authors: Druker BJ Guilhot F O'Brien SG et al.

Source: New England Journal of Medicine. 12/7/2006, Vol. 355 Issue 23, p2408-2504. 14p.

Hypereosinophilic syndrome.

Authors: Roufosse FE Goldman M Cogan E et al.

Source: New England Journal of Medicine. 6/26/2003, Vol. 348 Issue 26, p2687-2687. 1p.

Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Authors: Chung J Vallurupalli M Noel S et al.

Source: Science (New York, N.Y.) [Science] 2026 Apr 09; Vol. 392 (6794), pp. eady5196. Date of Electronic Publication: 2026 Apr 09.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.

Authors: Aguirre LE Stone RM DeAngelo DJ et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Nov 04; Vol. 15 (1), pp. 192. Date of Electronic Publication: 2025 Nov 04.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysis.

Authors: Drucker M Lee D Bowman M et al.

Source: Blood [Blood] 2026 Jun 25; Vol. 147 (26), pp. 3209-3216.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemia.

Authors: Weisberg E Chowdhury B Garg S et al.

Source: Haematologica [Haematologica] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

Authors: Lee D Abu-Shihab Y Plas K et al.

Source: Leukemia [Leukemia] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.

Authors: Pollyea DA Altman JK Assi R et al.

Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Jun; Vol. 24 (6), pp. 222-229.

Publication Type: Journal Article; Practice Guideline

Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Authors: Wu H Hu C Wang A et al.

Source: Leukemia [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1342.

Publication Type: Expression of Concern

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.

Authors: Chen EC Liu Y Bell HL et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 May 26. Date of Electronic Publication: 2026 May 26.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

HMA + venetoclax triplet regimens for the initial treatment of AML in adults- CONTRA.

Authors: Stahl M Stone RM

Source: Blood advances [Blood Adv] 2026 May 21. Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

Authors: Silva WF Jr Yin J Liedtke M et al.

Source: Blood advances [Blood Adv] 2026 May 08. Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Authors: Aguirre LE Kim HT Elmariah H et al.

Source: Blood advances [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2817-2828.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

CPX-351 selectively benefits patients with AML and myelodysplasia-related mutations in the pivotal randomized trial.

Authors: Shimony S Murdock HM Keating J et al.

Source: Blood advances [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2854-2864.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Prevalence and impact of frailty assessed using standard geriatrics tools in older adults with blood cancers.

Authors: DuMontier C Cronin AM Hshieh TT et al.

Source: Haematologica [Haematologica] 2026 Apr 23. Date of Electronic Publication: 2026 Apr 23.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Das not enough in CBF AML.

Authors: Stone RM; Dana-Farber Cancer Institute.

Source: Blood [Blood] 2026 Apr 09; Vol. 147 (15), pp. 1658-1659.

Publication Type: Editorial; Comment

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE; In Process